1.Analysis of SCI-indexed biomedical journals:a comparison between China,Japan,India and South Korea
Danghui YU ; Huiliang GAN ; Yan SUN ; Cha YIN ; Xueli WEI ; Yanjuan ZHOU ; Zejun JIA
Journal of Navy Medicine 2015;(4):366-367
Objective To analyze the number and quality of biomedical journals of different countries,so as to evaluate the situation of their biomedical research.Methods We searched and analyzed the Journal citation report published by Thomson Reuters. The information of biomedical journals of four countries:China,Japan,India,and South Korea,was collected,and was subjected to statistical analysis.Results It was found that China had the least number of biomedical journals,and it accounted for the lowest ratio of its total journals.However,the quality of Chinese biomedical journals was in the lead among the four countries.The impact factor of Chinese journals was obviously higher than those of the other three groups.Compared with Japan,the numbers of Chinese biomedical journals was less for different academic areas.Conclusion China has comparatively small number of SCI-indexed biomedical journals, and the situation should be improved from both number and quality aspects,so that our biomedical journal become a part of the interna-tional biomedical publishing community.
2.Salmeterol/fluticasone combined with N-acetylcysteine in treatment of airway inflammation of stable chronic obstructive pulmonary disease
Shilun YU ; Guangjun JIANG ; Hong GUO ; Jing LI ; Tongjun LIU ; Xueli CHA ; Qingdong OU ; Dawei WU
Chinese Journal of General Practitioners 2008;7(11):754-757
Objective To evaluate salmeterol/fluficasone combined with N-acetylcysteine in treatment of stable chronic obstructive pulmonary disease (COPD). Methods Sixty patients with stable COPD were randomized into treatment group(n = 30) and control group(n = 30). Patients in control group were given salmeterol/fluticasone twice per day ; while patients in treatment group in addition to salmeterol/ fluticasone, also took N-acetylcysteine 0.6 g three times per day. The course of treatment lasted for four weeks. Pulmonary function was measured in all patients; interleukin-8 (IL-8), tumor necrosis factor α (TNF-α), superoxide dismntase (SOD) and malondialdehyde (MDA) in blood serum and induced sputum were determined. The white cell count and classification in sputum smear was examined and the quality of life (QOL) of patients was evaluated. Results FEV1, FEV1 %, QOL evaluation, IL-8, TNF-α, white cell count and the percentage of neutrophil granulocytes in induced sputum after treatment were significantly improved compared with those before treatment in control group (P <0.05 or P <0.01). FEV1, FEV1%, QOL evaluation, SOD and MDA in blood serum, IL-8, TNF-α, SOD and MDA, total white cell count, the percentage of neutrophil granulocytes and macrophage in induced sputum after treatment were significantly improved in treatment group (P <0. 05 or P <0.01). The differences in SOD and MDA in blood serum and the percentage of neutrophil granulocytes in induced sputum smear between treatment group and control group were staffsticaUy significant (93 ± 8) × 10-6 U/L, (4. 0 ± 1.0) × 10-3 mmol/L and 0. 5 ± 0. 3 vs (85 ± 10) ×10-6U/L,(4.2±1.1) ×10-3mmol/Land0.6±0.2; allP<0.05. Conclusion Combination of salmeterol/fluticasone and N-acetylcysteine has better therapeutic results in treatment of airway inflammation of stable COPD.

Result Analysis
Print
Save
E-mail